NorthWest Biotherapeutics Inc (NWBO)

[biosectinvestor]

I do not necessarily think additional bells and whistles for manufacturing would hold up the application, though I know that is a much stated opinion.

I do think they are going methodically with MHRA because the agency seems way more enthusiastic and friendly and that will be a good way to set-up other applications.

I do not necessarily believe there is any higher barriers or likelihood of problems at FDA, but I do think the MHRA process has been so much friendlier that they will have a very good idea ahead of time to avoid challenges at FDA. And of course they know there might be trolls in wait seeking to undermine or slow their progress and I think they may believe those trolls would likely be far less influential once they are already approved elsewhere.

The attorneys get the same percentage whether they go to trial or not. Plaintiffs don’t pay a lot unless they think things are getting real. It doesn’t mean everyone will wait to settle until actual trial, and for some, discovery might not be a worry at all. But for some, that could be the key event or unflattering info could come out then and make settlement at all costs better than going to trial. Timing is often valuable and waiting is often the best strategy for getting anything valuable.